GlassScriptPhysician profile
Nisha Kalia
NPI 1902139330
$740.31
in general payments reported to CMS, 2019-2025
13 companies · $78.76 in 2025
The $78.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.98 · 2022: $54.01 · 2023: $367 · 2024: $210 · 2025: $78.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.32 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.74 | 2023-2024 | |
| Astellas Pharma US INC | $167.66 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $122.44 | 2023-2025 | Nexplanon |
| Aspira Women'S Health INC | $54.01 | 2022 | |
| Amag Pharmaceuticals, INC. | $30.98 | 2019 | |
| Agile Therapeutics, INC. | $21.23 | 2024 | Twirla |
| Exeltis, USA INC. | $21.17 | 2024 | Slynd |
| Medtronic, INC. | $19.96 | 2024 | Interstim |
| Hologic Sales and Service, LLC | $18.75 | 2024 | Aptima |
| Millicent US INC | $17.98 | 2025 | Intrarosa, Femlyv |
| Sumitomo Pharma America, INC. | $16.99 | 2023 | Myfembree |
| Smith+Nephew, INC. | $16.22 | 2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Evofem Biosciences, INC. | $14.18 | 2023 | Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Kalia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.